Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

Clinical Trial to Test Ketamine to Treat Rett Syndrome

Ketamine vials (Licensed under Public Domain via Wikimedia Commons)

23 March 2015. A clinical trial is planned to test an anesthetic used in surgery as a treatment for Rett syndrome, a rare developmental disorder affecting girls. The trial testing the anesthetic ketamine will be conducted by Case Western Reserve University medical school in . . . → Read More: Clinical Trial to Test Ketamine to Treat Rett Syndrome

Biotechs Partner on Cancer Stem Cell-Gene Therapies

(NIH.gov)

23 March 2015. Two biotechnology companies are combining their expertise in neural stem cells and gene delivery to develop new cancer therapies that the parties say would be more effective with fewer side effects than chemotherapy drugs used today. While GenVec Inc. in Gaithersburg, Maryland will participate economically in the collaboration with . . . → Read More: Biotechs Partner on Cancer Stem Cell-Gene Therapies

Alcohol Ignition Locks Seen Preventing 83% of DUI Deaths

(Oregon Department of Transportation, Flickr)

20 March 2015. A statistical projection shows some 59,500 deaths over 15 years could be prevented if new cars in the U.S. had alcohol ignition locks that stop drunk drivers from starting their engines. Medical and transportation researchers at University of Michigan, led by professor of emergency medicine . . . → Read More: Alcohol Ignition Locks Seen Preventing 83% of DUI Deaths

New Adaptive Aircraft Control System Flight Tested

Students and professors from the USAF Test Pilot School and University of Illinois. Naira Hovakimyan is second from the left. (Rebecca Amber, USAF)

20 March 2015. U.S. Air Force pilots tested a new flight control system designed by engineers at University of Illinois that automatically adapts aircraft to changing conditions faster than most . . . → Read More: New Adaptive Aircraft Control System Flight Tested

Lilly Acquiring Treatment for Autoimmune Disorders

(NIH)

19 March 2015. The pharmaceutical company Eli Lilly and Company is acquiring from Hanmi Pharmaceutical, an experimental drug that blocks the actions of an enzyme associated with rheumatoid arthritis and other autoimmune diseases. The deal can pay Hanmi, in Seoul, Korea, as much as $690 million.

Autoimmune disorders are diseases where the . . . → Read More: Lilly Acquiring Treatment for Autoimmune Disorders

UC-Davis Spins Off Irrigation Technology Start-Up

Tom Shapland (Univ of California, Davis)

19 March 2015. A graduate student in agriculture at University of California in Davis turned his research on irrigation technology into a new enterprise addressing the chronic drought conditions facing that state’s farmers. Tom Shapland started Tule Technologies Inc. in January 2014 that licensed his research measuring . . . → Read More: UC-Davis Spins Off Irrigation Technology Start-Up

Report: Affordable Care Act Remaking U.S. Health Sector

Presidential signature on the Affordable Care Act (whitehouse.gov)

18 March 2015. As the U.S. approaches the fifth anniversary of the Affordable Care Act, a new report from consulting firm PricewaterhouseCoopers highlights five major trends transforming the country’s health care sector, including creation of 90 new companies. The report, “Healthcare reform: Five trends to . . . → Read More: Report: Affordable Care Act Remaking U.S. Health Sector

Sensor-Bandage Device Detects Early Forming Bedsores

Sensor-bandage to detect tissue damage leading to bedsores (Univ of California, Berkeley)

18 March 2015. A device with tiny electronic sensors in a flexible bandage is able to detect the earliest stages of tissue damage leading to pressure ulcers or bedsores, in tests with lab animals. The findings of research engineers from University . . . → Read More: Sensor-Bandage Device Detects Early Forming Bedsores

Cloud Pharma, Univ of Florida Partner on Cancer Drug Design

(PublicDomainPictures, Pixabay)

17 March 2017. Cloud Pharmaceuticals, a company designing drug compounds with computer-based tools, and University of Florida’s medical school are collaborating on the design of new drugs limiting an enzyme implicated in the proliferation of cancer cells. Financial terms of the partnership were not disclosed.

The agreement calls for the university’s . . . → Read More: Cloud Pharma, Univ of Florida Partner on Cancer Drug Design

U.K. Govt, Pharmas Form Dementia Research Fund

(NIH.gov)

17 March 2015. A coalition of the United Kingdom government, five pharmaceutical companies, and the foundation Alzheimer’s Research UK are creating a $100 million fund to finance early research into treatments and cures for dementia. The U.K. health minister Jeremy Hunt is scheduled to unveil the Dementia Discovery Fund at a World . . . → Read More: U.K. Govt, Pharmas Form Dementia Research Fund